Research on painful menses in Unani System of Medicine

Effect of Irsa in Usr-i-Tamth Tashannuji (Spasmodic Dysmenorrhea): A Randomized Controlled Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060539

Enrollment

Registered

2023-12-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Joshanda(decoction) of Irsa will be prepared by soaking 6g of irsa in 100ml of water overnight and then boiled till it reduces to half.: Orally once daily from D1-D5 of menses for 3 con

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 18-35 years. Both married and unmarried. Patients with regular menstrual cycle i.e., 21-35 days and painful menstruation. Visual Analogue Scale (VAS)Score >4.

Exclusion criteria

Exclusion criteria: Patients with systemic illness like hypertension, diabetes Mellitus, thyroid dysfunction, acute appendicitis, cholecystitis, renal calculi, acute gastroenteritis. Pelvic pathology like Pelvic inflammatory disease, uterine fibroids, adenomyosis, endometrial polyp. Allergic/ sensitive to NSAIDs.

Design outcomes

Primary

Measure	Time frame
Reduction in VAS scoreTimepoint: Every month before and after menstruation	—

Secondary

Measure	Time frame
Improvement in SF-12 scale for QoLTimepoint: Every month before and after menstruation	—

Countries

India

Contacts

Public ContactDr Aisha Anjum A

Government Unani Medical College and Hospital

dr.aanjuma@gmail.com8951592300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026